Scarica l'app Stockscreener
0.206
9.03%
-0.0221
Dopo l'orario di chiusura:
.21
0.004
+1.94%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cosmos Health Inc Borsa (COSM) Ultime notizie
Cosmos Health Secures Additional 180-Day Nasdaq Extension To Regain Bid Price Compliance - TradingView
Cosmos Health gets Nasdaq extension to regain $1 minimum bid price - Investing.com
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance - lincolnjournal.com
Cosmos Health CEO addresses shareholders amid stock decline - Investing.com UK
Cosmos Health targets $200M revenue by 2029, driven by U.S. expansion - scanx.trade
$20 Million in Liquid Assets Support Rapid Growth Including Acquisitions, Bio Pharma Production and Nanotechnology Initiatives for Diversified Global Heath Leader Cosmos Health, Inc. (Nasdaq: COSM) - Barchart.com
Cosmos Health (COSM) Secures Manufacturing Deal with Verisfield S.A. - GuruFocus
Cosmos Health subsidiary secures manufacturing deal - Investing.com
Cosmos Health Inc. - Via Ritzau
Cosmos Health CEO addresses shareholders amid stock decline By Investing.com - Investing.com Canada
Cosmos Health CEO Issues Letter to Shareholders: Building - GlobeNewswire
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway - Yahoo Finance
Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com UK
Cosmos Health (COSM) Launches New Capsule Production and Signs C - GuruFocus
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com Canada
Cosmos Health Inc. Subsidiary Cana Laboratories Inaugurates New Capsule Production Line and Secures Contract with Provident Pharmaceuticals - Quiver Quantitative
Factory upgrade backs 385,000-dose antidepressant deal contract - Stock Titan
Cosmos Health (COSM) Expands Innovation with Patent Acquisition - GuruFocus
Cosmos Health subsidiary acquires nanotechnology patent By Investing.com - Investing.com Australia
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives - The Manila Times
Cosmos Health subsidiary acquires nanotechnology patent - Investing.com
Cosmos Health Inc. Subsidiary Cana Laboratories Acquires International Patent to Enhance Nanotechnology Investment Initiatives - Quiver Quantitative
Cosmos Health Completes Acquisition of Strategic - GlobeNewswire
New nanotech patent backs Cosmos Health’s next-gen pharma plans - Stock Titan
Andreas Bovopoulos holds 4.32M Cosmos Health (COSM) shares — Schedule 13G/A - Stock Titan
Cosmos Health Inc.: Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories - FinanzNachrichten.de
Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories - The Manila Times
New Oliv18 capsule packs 11 tsp of olive oil for heart support - Stock Titan
Key facts: Cosmos Health may monetize ~$15M assets; lists 96 products EU - TradingView
Cosmos Health Inc. (NASDAQ: COSM) $200M shelf; discloses crypto treasury strategy - Stock Titan
Cosmos Health expands Sky Premium Life to all 27 EU states - Investing.com UK
Cosmos Health launches Fort18 men’s wellness supplement in U.S. - Investing.com
$65.3 Million Revenue in 2025 Followed by Q1 2026 Record of $17.9 Million with Momentum Continuing in Q2 for Diversified Global Heath Leader Cosmos Health Inc. (Nasdaq: COSM) - Barchart.com
Cosmos Health expands Sky Premium Life to all 27 EU states By Investing.com - Investing.com South Africa
Vitamins brand Sky Premium Life goes on sale in all 27 EU countries - Stock Titan
Cosmos Health (COSM) to Explore Monetization of Non-Core Assets - GuruFocus
Cosmos Health explores sale of non-core assets worth $20M By Investing.com - Investing.com India
Cosmos Health explores sale of non-core assets worth $20M - Investing.com Nigeria
Cosmos Health Identifies Approximately $20 Million in - GlobeNewswire
Cosmos Health Inc. Identifies $20 Million in Non-Core Assets for Potential Monetization - Moomoo
Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value - The Globe and Mail
Cosmos Health Bets the Farm—Literally—on a $20 Million Revival Plan - BriefGlance
Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029 - WBOC TV
Cosmos Health (NASDAQ: COSM) outlines 2026 proxy, 10M-share equity plan and Series B preferred - Stock Titan
Cosmos Health reports balance sheet improvements, EIB talks By Investing.com - Investing.com South Africa
Cosmos Health reports balance sheet improvements, EIB talks - Investing.com
Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent S - The Manila Times
Cosmos Health trims $4.5M debt, weighs €25M EIB deal, drops 38% warrants - Stock Titan
Cosmos Health Provides Balance Sheet Update: Highlights - GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Cosmos Health extends C-Scrub brand into veterinary market By Investing.com - Investing.com South Africa
Cosmos Health enters animal health market with C-Scrub brand - Yahoo Finance
14.34%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):